Insights

Medtech Connect | Beyond COVID-19 - investigating and innovating for the next generation 

People with diabetes have an increased risk of developing serious health problems, including neuropathy. We’ve developed an AI-based system, in partnership with eminent specialists, to assess the presence of neuropathy from retinal images.

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is launching a Roundtable webinar series on digital devices for 2021. Presented by subject matter experts in the pharmaceutical sciences, this is a unique opportunity to learn about the latest research and regulatory trends focused on digital devices.

Is now the time for AI and digital tech to revolutionise the whole field of pathology? Andrew Goulter, VP, Life Sciences at Cambridge Consultants certainly thinks so, as he explains here. 

Joe Corrigan, Head of Intelligent Healthcare, joined a panel of experts at MWC 2021 to share recent breakthroughs which have used AI to disrupt the healthcare industry and save lives.

Regulatory approval for ophthalmic combination products is like gold dust. The final instalment in our ophthalmology series walks you through the challenges and helps plot a route to market.

Innovation in drug delivery devices has evolved at a constant pace for 30 years. But what's next? Our belief is that we sit on the cusp of a decade of innovation and commercial opportunity in active implants.

The number of effective cell and gene therapies is growing rapidly, especially for treating ocular diseases. However, much less attention has been focused on the critical issue of delivery to the eye. 

If you’re a surgical robotics start-up, the timing of your risk assessment will determine the level of success you achieve. Andrew Savarese, VP, Surgical Robotics & Advanced Surgical Systems, delves into his deep experience and comes up with crucial advice to make sure you spend the right money once, not the wrong money twice.

The pandemic has compressed a decade of incremental change into a matter of months. Medical device companies sit on the cusp of radical change. Gavin Troughton, Head of Acute and Critical Care, surveys the fast changing landscape and poses the questions that can inform your digital transformation play…

Diagnosing cancer early to treat it more effectively is vital. Here, Josh Gibson, senior physicist at Cambridge Consultants, unveils a potentially life-saving breakthrough in the field of liquid biopsy that’s been hailed by a leading innovation award jury…

Intraocular lens (IOL) delivery devices are the next frontier for innovation and differentiation. As the optical quality of the IOL is reaching its apex, there's little room for competitive differentiation in the lens itself. Tim Phillips explores the improvements to IOL delivery devices that could reduce complications, streamline delivery workflow and improve postoperative patient satisfaction.